Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HANDHELD ENTERTAINMENT, INC. | 42,241 | reported | 01 Sept 2007 | tx 1+25,000 |
| NEORX CORP | 36,144 | reported | 09 Jun 2011 | tx 31+1,774,763−395,626 |
| Epizyme, Inc. | 8,994 | reported | 12 Aug 2022 | tx 37+4,419,381−14,916,530 |
| Enliven Therapeutics, Inc. | 8,500 | reported | 02 Jun 2022 | tx 2+16,228 |
| MAP Pharmaceuticals, Inc. | 7,500 | reported | 20 May 2010 | tx 14+2,362,077−2,780,807 |
| Galecto, Inc. | 1,440 | reported | 18 Jun 2025 | tx 13+1,198,183−403,530 |
| CymaBay Therapeutics, Inc. | 0 | reported | 07 Feb 2019 | tx 35+149,555−136,079 |
| EnteroMedics Inc | 0 | reported | 25 May 2017 | tx 51+13,108,018−5,517,201 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | Galecto, Inc. | 1,440 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Galecto, Inc. | 36,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 36,000 | 0.00 USD | deriv |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 3,380,951 | — | |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 13,060 | — | |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 8,994 | — | |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 36,000 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Enliven Therapeutics, Inc. | 8,500 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 8,994 | 0.00 USD | |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 41,006 | 0.00 USD | deriv |
| 17 Nov 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 29 Jun 2021 | GRANT_AWARD | Enliven Therapeutics, Inc. | 7,728 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | Epizyme, Inc. | 8,060 | 0.00 USD | |
| 11 Jun 2021 | GRANT_AWARD | Epizyme, Inc. | 40,559 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 11 Nov 2020 | PURCHASE | Epizyme, Inc. | 5,000 | 12.07 USD | first after silence |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 1,020,036 | — | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 19,432 | — | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 9,587 | — | |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 3,688 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 392,367 | 0.00 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 7,475 | 0.00 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 3,688 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | Epizyme, Inc. | 14,013 | 0.00 USD | deriv |
| 31 May 2019 | GRANT_AWARD | Epizyme, Inc. | 17,633 | 0.00 USD | deriv |
6 purchases reported after at least 12 months of silence — most recent on 11 Nov 2020.